We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.025 | -2.94% | 0.825 | 0.80 | 0.85 | 0.85 | 0.7925 | 0.85 | 823,510 | 16:06:06 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.44 | 1.48M |
TIDMN4P
RNS Number : 1153H
N4 Pharma PLC
08 March 2018
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) ----------------------------------------------------------------------------------- 1. Identity of the issuer or N4 PHARMA PLC the underlying issuer of existing shares to which voting rights are attached: (ii) ----------------------------------------------------------- ---------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ----------------------------------------------------------------------------------- An acquisition or disposal of voting rights ------------------------------------------------------------ --------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------ --------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------ --------------------- An event changing the breakdown of voting rights X ------------------------------------------------------------ --------------------- Other (please specify): ---------------------------------------------------------- --------------------- 3. Full name of person(s) NIGEL JAMES THEOBALD subject to the notification obligation: (iii) ----------------------------------------------------------- ---------------------- 4. Full name of shareholder(s) (if different from 3.):(iv) ----------------------------------------------------------- ---------------------- 5. Date of the transaction 8 MARCH 2018 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- ---------------------- 8 MARCH 2018 ----------------------------------------------------------- ---------------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) 19% ----------------------------------------------------------- ---------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- -------------------------------- --------------------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ------------- --------------- --------------- ------------- --------------------------- ------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ----------- ----------- ------------- ------------- ------------ ------------ ----------- GB00BYW8QM32 16,846,633 16,846,633 16,846,633 16,846,633 18.91% --------------- --------------- ------------- ------------- ------------ ------------ ----------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- ------------- ------------------------------ ----------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- ------------- ------------- --------------- ----------------------------- ----------------------- Nominal Delta --------------- ------------- ------------- --------------- ----------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ------------------------------------------------- ------------------------------------------------------------------- 16,846,633 18.91% ------------------------------------------------- ------------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ---------------------------------------------------------------------------------------------- Proxy Voting: ---------------------------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- ------------------------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- ------------------------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- ------------------------------- 13. Additional information: The Company's issued share capital increased on 8 March 2018 as a result of exercises of warrants ------------------------------------------------------------- ------------------------------- 14. Contact name: Nigel Theobald ------------------------------------------------------------- ------------------------------- 15. Contact telephone number: + 44 1332 690061 ------------------------------------------------------------- -------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLLFIIVVITIIT
(END) Dow Jones Newswires
March 08, 2018 05:05 ET (10:05 GMT)
1 Year N4 Pharma Chart |
1 Month N4 Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions